EDNRA and systemic sclerosis: In systemic sclerosis (SSc), for example, higher levels of autoantibodies against AT1R and ETAR (from now on: AT1R-AAs and ETAR-AAs) are associated with more severe manifestations of disease and predict SSc-related mortality [1].